DSIP 2mg — Vial Spec, Reconstitution Math & COA

Overview of the DSIP 2mg Vial Specification & Laboratory Utility

A 2mg vial of DSIP contains precisely 2.0 milligrams of high-purity, lyophilized nonapeptide powder (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) paired with an inert bulking agent to ensure cake stability. This specific mass option is routinely specified by academic and biotechnology laboratories conducting pilot feasibility studies, acute dosing assays in rodent models, or localized cellular binding protocols where larger volumetric yields are prone to waste or degradation prior to completion.

While PX1 Research maintains flexible catalog configurations—frequently supplying larger research quantities such as the DSIP 5mg format—the 2mg specification remains a critical baseline for investigators managing strict freeze-thaw limitations. To review all available unit sizes and complementary neuroendocrine peptides, researchers can consult our comprehensive catalog of all peptides. Every vial distributed by PX1 Research is strictly designated for laboratory research use only, serving as a non-clinical reagent for biochemical and physiological inquiry.

Peptide Chemistry & Molecular Profile of Delta-Sleep-Inducing Peptide

Delta-Sleep-Inducing Peptide is an endogenous neuropeptide original isolated from the hemodialysate of sleeping rabbits. It exhibits an exact molecular weight of 848.81 g/mol and a molecular formula of C35H48N10O15. The primary structure features an N-terminal tryptophan coupled through a series of aliphatic and polar amino acids to a C-terminal glutamic acid residue.

Preclinical literature demonstrates that the structural integrity of the tryptophan residue at position 1 and the dicarboxylic amino acid residues (aspartic acid and glutamic acid) are essential for biological activity. In vitro ligand-binding assays indicate that DSIP interacts with specific central nervous system receptor sites, although an isolated, single cloned 'DSIP receptor' remains a subject of ongoing characterization. The peptide displays high solubility in aqueous buffer systems, rendering it highly adaptable for diverse cell culture and microperfusion assays.

Preclinical Research Context: Sleep Architecture & Stress-Axis Modulation

In preclinical model systems, DSIP is primarily evaluated for its role as a sleep peptide, specifically regarding its influence on electroencephalographic slow-wave (delta) sleep patterns. Animal studies suggest that central or systemic administration of DSIP can increase delta-wave activity without suppressing REM sleep or inducing significant secondary hypnotic toxicity, setting it apart from traditional sedative pharmacological agents.

Beyond sleep-architecture modulation, neuroendocrine research demonstrates that DSIP plays a regulatory role within the hypothalamic-pituitary-adrenal (HPA) axis. In vitro assays using pituitary cell cultures and rodent stress models show that DSIP modulates the release of adrenocorticotropic hormone (ACTH) and corticosterone. Preclinical evidence indicates that the peptide acts as a homeostatic buffer during acute physiological stress, mitigating hyper-activation of the stress axis and supporting cell-level recovery processes during rest cycles.

Precision Reconstitution Math for 2mg Lyophilized Mass

Accurate reconstitution is vital for maintaining experimental reproducibility and target concentration integrity in cell culture microplates or microinjection apparatuses. Adding precise volumes of sterile diluent directly into the 2mg DSIP vial yields predictable final concentrations. Researchers can utilize our interactive reconstitution calculator to adapt these formulas for specialized micro-volumetric protocols.

The mathematical relationship between diluent volume ($V$) in milliliters and target concentration ($C$) in milligrams per milliliter for a 2.0 mg cake is expressed as $C = \frac{2.0\text{ mg}}{V\text{ (mL)}}$. Standard volumetric scenarios include:

• Reconstitution with 1.0 mL Diluent: Yields a final concentration of 2.0 mg/mL (2000 µg/mL). A 10 µL transfer volume delivers exactly 20 µg of active peptide compound.

• Reconstitution with 2.0 mL Diluent: Yields a final concentration of 1.0 mg/mL (1000 µg/mL). A 10 µL transfer volume delivers exactly 10 µg of active peptide compound.

• Reconstitution with 3.0 mL Diluent: Yields a final concentration of 0.67 mg/mL (666.7 µg/mL). A 15 µL transfer volume delivers approximately 10 µg of active peptide compound.

Aliquot Planning & Diluent Compatibility in Preclinical Protocols

To preserve the primary sequence and secondary structural stability of DSIP, selecting the appropriate diluent is essential. For short-term assays intended for immediate execution within 24–48 hours, unpreserved 0.9% Sterile Sodium Chloride or target cell-culture media may be utilized. However, for multi-day protocols, Bacteriostatic Water containing 0.9% benzyl alcohol is recommended to inhibit microbial proliferation.

Lyophilized peptides undergo rapid physical degradation upon repeated cycles of freezing and thawing. Laboratory investigators should establish an aliquot workflow immediately following fluid addition. The reconstituted solution should be gently swirled—never vortexed—until fully clear, drawn into single-use polypropylene micro-centrifuge tubes at calculated working volumes, and immediately stored at -20°C or -80°C until assay deployment.

Quality Control & COA Verification for PX1 Research Batches

PX1 Research ensures that every batch of DSIP adheres to stringent analytical benchmarks. Our peptides are USA-manufactured in GMP-compliant facilities and undergo comprehensive identity, purity, and safety testing through an independent, ISO 17025 accredited laboratory prior to release.

Analytical validation includes High-Performance Liquid Chromatography (HPLC) to confirm peptide purity exceeds 98.0%, combined with Mass Spectrometry (MS) to verify precise molecular weight (848.81 Da) without residual truncation fragments. Furthermore, every lot undergoes chromogenic LAL assays to ensure endotoxin levels remain strictly below <0.01 EU/mg, preventing confounding inflammatory responses in sensitive cell lines or rodent models. Researchers can review batch-specific data by accessing our public COA repository.

Selecting Vial Volumes: 2mg vs 5mg Configuration Analysis

Determining whether to specify a 2mg vial or transition to a larger format depends primarily on daily volume consumption, experiment timeline, and budgetary efficiency. The 2mg vial format is ideal for short-term projects, pilot toxicity screens, or laboratories conducting lower-frequency analytical runs where a reconstituted vial would otherwise exceed its 28-day stability window prior to usage.

Conversely, high-throughput animal model studies requiring continuous daily administration across multiple cohorts benefit from larger single-vial masses. Transitioning to a DSIP 5mg unit reduces vial turnover, decreases per-milligram reagent acquisition costs, and simplifies master-mix prep for large-scale study blocks. Both formats maintain identical raw chemical purity, synthesized under the exact same stringent manufacturing parameters.

Comparative Analysis: DSIP alongside Related Neuroendocrine Research Compounds

When evaluating neuroendocrine, circadian, or stress-axis modulation pathways, investigators frequently compare DSIP with other specialized peptides. For example, researchers investigating broader cellular repair, pineal gland signaling, and circadian regulation often study DSIP in parallel with Epithalon or Pinealon, both of which target central neuro-epithalamic gene expression and telomerase pathways in preclinical models.

Similarly, laboratories evaluating downstream hypothalamic signaling, growth factor release, and metabolic restoration during deep rest cycles frequently benchmark DSIP against growth hormone secretagogues such as Sermorelin. While secretagogues like Sermorelin alter pituitary somatotropes directly, DSIP functions via distinct electrophysiological and neuromodulatory pathways, offering a complementary mechanism of action in neuroendocrine research libraries.

Storage, Stability, and Handling Guidelines

Upon arrival at the laboratory facility, lyophilized DSIP vials should be maintained in a dry, dark environment at -20°C for long-term storage (stable up to 24 months). If short-term bench top storage is required prior to reconstitution, the dry powder remains stable at room temperature (15°C to 25°C) for up to several weeks, though cold storage is preferred to maintain peak potency.

Once reconstituted with bacteriostatic diluent, liquid solutions must be refrigerated at 2°C to 8°C and used within 28 days. Exposure to direct ultraviolet light, high heat, or vigorous mechanical agitation (vortexing) can induce cleavage of the sensitive N-terminal tryptophan residue or promote aggregation. Researchers should adhere to aseptic laboratory technique throughout all dilution and transfer procedures.

Sourcing & Procurement via PX1 Research

PX1 Research serves as a premier USA supplier of verified research peptides for academic institutions, contract research organizations (CROs), and private biotechnology facilities. Orders are processed swiftly and dispatched from our primary distribution hubs in California and Arizona, providing guaranteed same-day shipping for orders placed Monday through Friday prior to cutoff times.

To explore custom synthesis options, multi-vial project quotes, or establish a dedicated corporate purchasing account, laboratory buyers are encouraged to visit our wholesale portal. Additional literature detailing technical methodologies and peptide handling protocols is accessible through our centralized research library.